| 0 |
ACHLORHYDRIA |
1 |
0.0143 |
| 1 |
OCHRONOSIS |
1 |
0.0141 |
| 2 |
MYOCARDIAL STUNNING |
1 |
0.0075 |
| 3 |
ATRIOVENTRICULAR DISSOCIATION |
1 |
0.0047 |
| 4 |
MINERAL DEFICIENCY |
1 |
0.0036 |
| 5 |
BUNDLE BRANCH BLOCK LEFT |
15 |
0.0035 |
| 6 |
NODAL ARRHYTHMIA |
2 |
0.0023 |
| 7 |
METAPLASIA |
1 |
0.0021 |
| 8 |
URETHRITIS |
1 |
0.0018 |
| 9 |
BUNDLE BRANCH BLOCK RIGHT |
8 |
0.0017 |
| 10 |
URINARY TRACT INFECTION PSEUDOMONAL |
1 |
0.0017 |
| 11 |
SUPRAVENTRICULAR EXTRASYSTOLES |
5 |
0.0015 |
| 12 |
VENTRICULAR EXTRASYSTOLES |
15 |
0.0014 |
| 13 |
OXYGEN SUPPLEMENTATION |
1 |
0.0014 |
| 14 |
CEREBELLAR ATROPHY |
1 |
0.0011 |
| 15 |
PARTNER STRESS |
1 |
0.0010 |
| 16 |
ATRIAL TACHYCARDIA |
2 |
0.0010 |
| 17 |
BLADDER OPERATION |
1 |
0.0009 |
| 18 |
CARDIOACTIVE DRUG LEVEL INCREASED |
1 |
0.0008 |
| 19 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 20 |
PULMONARY VALVE INCOMPETENCE |
1 |
0.0007 |
| 21 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 22 |
HYPERTENSIVE HEART DISEASE |
1 |
0.0005 |
| 23 |
ATROPHY |
1 |
0.0005 |
| 24 |
APPLICATION SITE SCAB |
1 |
0.0005 |
| 25 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
2 |
0.0005 |
| 26 |
METHAEMOGLOBINAEMIA |
1 |
0.0004 |
| 27 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 28 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 29 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 30 |
BLOOD PRESSURE DECREASED |
17 |
0.0003 |
| 31 |
ATRIAL FLUTTER |
2 |
0.0003 |
| 32 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 33 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 34 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 35 |
CHAPPED LIPS |
1 |
0.0002 |
| 36 |
HAEMORRHAGIC ANAEMIA |
1 |
0.0002 |
| 37 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 38 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 39 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 40 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 41 |
SKIN ATROPHY |
1 |
0.0002 |
| 42 |
SINUS HEADACHE |
1 |
0.0002 |
| 43 |
POLYP |
1 |
0.0002 |
| 44 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 45 |
ONYCHOCLASIS |
1 |
0.0001 |
| 46 |
DIVERTICULUM |
1 |
0.0001 |
| 47 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 48 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 49 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 50 |
TORSADE DE POINTES |
1 |
0.0001 |
| 51 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 52 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 53 |
MULTI-ORGAN FAILURE |
2 |
0.0001 |
| 54 |
CARDIAC MURMUR |
1 |
0.0001 |
| 55 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 56 |
FLANK PAIN |
1 |
0.0001 |
| 57 |
PARKINSONISM |
1 |
0.0001 |
| 58 |
COELIAC DISEASE |
1 |
0.0001 |
| 59 |
KNEE OPERATION |
1 |
0.0001 |
| 60 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 61 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 62 |
BACK INJURY |
1 |
0.0001 |
| 63 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 64 |
EYE INFECTION |
1 |
0.0001 |
| 65 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 66 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 67 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 68 |
ATAXIA |
1 |
0.0001 |
| 69 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 70 |
ELECTROCARDIOGRAM QT PROLONGED |
3 |
0.0001 |
| 71 |
BURSITIS |
1 |
0.0001 |
| 72 |
ILEUS |
1 |
0.0001 |
| 73 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 74 |
APPLICATION SITE ERYTHEMA |
2 |
0.0001 |
| 75 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 76 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 77 |
DRUG TOXICITY |
1 |
0.0001 |
| 78 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 79 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 80 |
TENDONITIS |
1 |
0.0001 |
| 81 |
DELUSION |
1 |
0.0001 |
| 82 |
ARRHYTHMIA |
3 |
0.0001 |
| 83 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 84 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 85 |
CANDIDA INFECTION |
1 |
0.0001 |
| 86 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 87 |
HEART RATE DECREASED |
2 |
0.0001 |
| 88 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 89 |
GASTRIC ULCER |
1 |
0.0001 |
| 90 |
SPINAL FRACTURE |
1 |
0.0000 |
| 91 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 92 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 93 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 94 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 95 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 96 |
PRESYNCOPE |
1 |
0.0000 |
| 97 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 98 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 99 |
FLUID RETENTION |
2 |
0.0000 |
| 100 |
HEPATITIS |
1 |
0.0000 |
| 101 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 102 |
GASTRITIS |
1 |
0.0000 |
| 103 |
PAIN IN JAW |
1 |
0.0000 |
| 104 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 105 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 106 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 107 |
HIP FRACTURE |
1 |
0.0000 |
| 108 |
SYNCOPE |
3 |
0.0000 |
| 109 |
GAIT INABILITY |
1 |
0.0000 |
| 110 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 111 |
HYPOXIA |
1 |
0.0000 |
| 112 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 113 |
DYSURIA |
1 |
0.0000 |
| 114 |
EPISTAXIS |
2 |
0.0000 |
| 115 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 116 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 117 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 118 |
ANGIOEDEMA |
1 |
0.0000 |
| 119 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 120 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 121 |
RENAL DISORDER |
1 |
0.0000 |
| 122 |
DYSPHAGIA |
2 |
0.0000 |
| 123 |
THERAPY CESSATION |
1 |
0.0000 |
| 124 |
BRADYCARDIA |
1 |
0.0000 |
| 125 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 126 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 127 |
SEPSIS |
2 |
0.0000 |
| 128 |
BLISTER |
1 |
0.0000 |
| 129 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 130 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 131 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 132 |
RENAL FAILURE |
2 |
0.0000 |
| 133 |
WEIGHT DECREASED |
4 |
0.0000 |
| 134 |
BURNING SENSATION |
1 |
0.0000 |
| 135 |
INJURY |
1 |
0.0000 |
| 136 |
HOT FLUSH |
1 |
0.0000 |
| 137 |
ARTHRITIS |
1 |
0.0000 |
| 138 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 139 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 140 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 141 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 142 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 143 |
CHEST PAIN |
2 |
0.0000 |
| 144 |
CARDIAC DISORDER |
1 |
0.0000 |
| 145 |
CONTUSION |
1 |
0.0000 |
| 146 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 147 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 148 |
ARTHRALGIA |
4 |
0.0000 |
| 149 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 150 |
CONSTIPATION |
2 |
0.0000 |
| 151 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 152 |
WEIGHT INCREASED |
2 |
0.0000 |
| 153 |
DECREASED APPETITE |
2 |
0.0000 |
| 154 |
PALPITATIONS |
1 |
0.0000 |
| 155 |
VOMITING |
4 |
0.0000 |
| 156 |
JOINT SWELLING |
1 |
0.0000 |
| 157 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 158 |
VISION BLURRED |
1 |
0.0000 |
| 159 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 160 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 161 |
DRUG INTERACTION |
1 |
0.0000 |
| 162 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 163 |
TREMOR |
1 |
0.0000 |
| 164 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 165 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 166 |
MYALGIA |
1 |
0.0000 |
| 167 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 168 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 169 |
MUSCLE SPASMS |
1 |
0.0000 |
| 170 |
ASTHENIA |
2 |
0.0000 |
| 171 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 172 |
ANAEMIA |
1 |
0.0000 |
| 173 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 174 |
HYPOTENSION |
1 |
0.0000 |
| 175 |
HYPERTENSION |
1 |
0.0000 |
| 176 |
BACK PAIN |
1 |
0.0000 |
| 177 |
FEELING ABNORMAL |
1 |
0.0000 |
| 178 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 179 |
DIZZINESS |
2 |
0.0000 |
| 180 |
NAUSEA |
3 |
0.0000 |
| 181 |
INSOMNIA |
1 |
0.0000 |
| 182 |
DYSPNOEA |
2 |
0.0000 |
| 183 |
ANXIETY |
1 |
0.0000 |
| 184 |
DIARRHOEA |
2 |
0.0000 |
| 185 |
PNEUMONIA |
1 |
0.0000 |
| 186 |
FATIGUE |
2 |
0.0000 |
| 187 |
DEATH |
2 |
0.0000 |
| 188 |
RASH |
1 |
0.0000 |
| 189 |
OFF LABEL USE |
2 |
0.0000 |
| 190 |
MALAISE |
1 |
0.0000 |
| 191 |
PAIN |
1 |
0.0000 |